Luis Z Avila

USPTO Granted Patents = 36 (Patent Applications = 6)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 12 (Patent Applications = 13)

Average Co-Inventor Count = 4.9

ph-index = 16

Forward Citations = 1,556(Granted Patents)

Location History:

Suwanee, GA (US) (2011)
Suwanee, ES (2012)
Bridgewater, NJ (US) (2016 - 2021)
Arlington, MA (US) (1997 - 2023)

Company Filing History:

University of Texas System

5. 3 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2025

Loading Chart...

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12252504 - Oligosaccharide-protein conjugates (2025-03-18),

2. 11701402 - Polypharmaceutical drug compositions and related methods (2023-07-18),

3. 11697690 - Site-specific glycoengineering of targeting moieties (2023-07-11),

4. 11279725 - Oligosaccharide-protein conjugates (2022-03-22),

5. 11160874 - Glycoengineered antibody drug conjugates (2021-11-02),

6. 10995148 - Site-specific glycoengineering of targeting moieties (2021-05-04),

7. 10907142 - Oligosaccharides comprising an aminooxy group and conjugates thereof (2021-02-02),

8. 10464962 - Oligosaccharide-protein conjugates (2019-11-05),

9. 10064952 - Glycoengineered antibody drug conjugates (2018-09-04),

10. 9611357 - Chemically modified dendrimers (2017-04-04),

11. 9493498 - Oligosaccharide-protein conjugates (2016-11-15),

12. 9469850 - Oligosaccharides comprising an aminooxy group and conjugates thereof (2016-10-18),

13. 9283247 - Chemically modified dendrimers (2016-03-15),

14. 8835614 - Oligosaccharide-protein conjugates (2014-09-16),

15. 8759501 - Oligosaccharides comprising an aminooxy group and conjugates thereof (2014-06-24),

Title: The Innovative Journey of Luis Z Avila: Pioneering Inventor in Arlington, MA

Introduction:

Luis Z Avila, a prolific inventor based in Arlington, MA, has made significant contributions to the field of pharmaceuticals through his groundbreaking patented innovations. With an impressive portfolio of 35 patents, Avila has been at the forefront of developing novel drug compositions and glycoengineering techniques to combat diseases like cancer.

Latest Patents:

1. Polypharmaceutical drug compositions and related methods: Avila's patent introduces compositions and methods for treating oral cancer by utilizing a poly-pharmaceutical drug with optimized ratios of bioactive compounds. This innovation aims to enhance the pharmacological characteristics for effective treatment.

2. Site-specific glycoengineering of targeting moieties: Avila's patent focuses on binding polypeptides and targeting moiety conjugates with site-specifically engineered glycan linkages. This advancement offers new possibilities in disease treatment by utilizing antigen-binding polypeptides with engineered glycans.

Career Highlights:

Avila has made significant contributions to renowned companies such as Genzyme Corporation and Focal, Inc., where he has played a pivotal role in driving innovation and advancing pharmaceutical research. His expertise and inventive spirit have been instrumental in developing cutting-edge solutions for complex medical challenges.

Collaborations:

Throughout his career, Avila has collaborated with esteemed professionals in the field, including coworkers like Arthur J Coury and Shikha P Barman. These collaborations have fostered a culture of innovation and knowledge sharing, leading to the successful development of revolutionary pharmaceutical technologies.

Conclusion:

Luis Z Avila's journey as an inventor showcases his unwavering commitment to pushing the boundaries of pharmaceutical research. Through his patented innovations and collaborative efforts, Avila continues to make a profound impact in revolutionizing the treatment landscape for diseases like cancer. His ingenuity and dedication serve as an inspiration for aspiring inventors and researchers in the quest for scientific excellence.

This text is generated by artificial intelligence and may not be accurate.